NCT05016557 (SCAM) is a NA clinical trial of Protein ingestion in Muscle Metabolism, sponsored by University of Exeter.

Who is sponsoring NCT05016557?

NCT05016557 is sponsored by University of Exeter.

What drugs are being tested in NCT05016557?

Interventions in NCT05016557: Protein ingestion.

What condition does NCT05016557 study?

NCT05016557 studies Muscle Metabolism.

Is NCT05016557 still recruiting?

NCT05016557 is currently completed. Last updated 11 January 2024.

Last reviewed 2024-01-11 · How we verify

NCT05016557: SCAM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Muscle Protein Synthetic Response of Algal and Fungal Protein

Completed NA Last updated 11 January 2024

What this trial tests

NA trial testing Protein ingestion in Muscle Metabolism in 36 participants. Completed in 24 June 2022.

Timeline

19 December 2020

Primary endpoint
24 June 2022

24 June 2022

Quick facts

Lead sponsor	University of Exeter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	36
Start date	19 December 2020
Primary completion	24 June 2022
Estimated completion	24 June 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Protein ingestion

Conditions studied

Muscle Metabolism — all drugs for Muscle Metabolism →

Sponsor

University of Exeter

Who can join

Adults 18 to 40, any sex, with Muscle Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dietary protein intake is vital for the maintenance of skeletal muscle mass and health. The production of animal-based proteins sources is associated with growing environmental and ethical challenges. As such, sustainable alternatives are needed. Algae are sustainably produced high-protein sources and it is predicted that algae will become one of the most consumed proteins in the next decades. However, the effects of algae on the stimulation of muscle mass growth are unknown. Therefore, we aim to assess the rate of digestion and absorption, and the effects on muscle growth of two types of algae (spirulina and chlorella) when compared to a sustainable non-animal derived fungal reference protein (mycoprotein), a source known to elicit a robust anabolic response.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Algae Ingestion Increases Resting and Exercised Myofibrillar Protein Synthesis Rates to a Similar Extent as Mycoprotein in Young Adults.
van der Heijden I, West S, Monteyne AJ, Finnigan TJA, et al · · 2023 · cited 13× · PMID 37716611 · DOI 10.1016/j.tjnut.2023.08.035

Verify or expand the search:

Other trials of Protein ingestion

Trials testing the same drug.

NCT04297137 — The Bioavailability of Multiple Novel, Sustainable, Non-animal Derived Protein Sources · NA · completed
NCT03147001 — Protein Ingestion Before Training Low · NA · completed

Other University of Exeter trials

Trials by the same sponsor.

NCT07457437 — Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA · recruiting
NCT06478121 — Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE) · recruiting
NCT06965699 — The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults · NA · recruiting
NCT06846294 — Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether · NA · not yet recruiting
NCT06852547 — The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adu · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05016557 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Exeter
Last refreshed: 11 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05016557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing